Pneumocystis polymerase chain reaction and blood (1/3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia

Journal of Infection and Chemotherapy

Volumn 20, Issue 2, 2014, Pages 109-114

  Matsumura, Yasufumi ^a   Ito, Yutaka ^a   Yamamoto, Masaki ^a   Matsushima, Aki ^a   Nagao, Miki ^a   Takakura, Shunji ^a   Iinuma, Yoshitsugu ^b   Ichiyama, Satoshi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Blood b D glucan; Immunocompromised host; Pneumocystis jirovecii pneumonia; Polymerase chain reaction

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIFUNGAL AGENT; BETA 1,3 GLUCAN; BILIRUBIN; CORTICOSTEROID; COTRIMOXAZOLE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PENTAMIDINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BACTERIAL SURVIVAL; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CANCER CHEMOTHERAPY; CANDIDEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COUGHING; DIET THERAPY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSPNEA; ESOPHAGUS CANDIDIASIS; FALSE POSITIVE RESULT; FEMALE; FEVER; FUNGAL DETECTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIA; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INTERSTITIAL PNEUMONIA; LEUKOCYTOSIS; LUNG ASPERGILLOSIS; LUNG HEMORRHAGE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PNEUMOTHORAX; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RADIATION PNEUMONIA; RISK FACTOR; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SILVER STAINING; SOLID TUMOR; SPARASSIS CRISPA; SPUTUM; SURVIVAL PREDICTION; SYSTEMIC MYCOSIS; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THRUSH; UNSPECIFIED SIDE EFFECT; UREA NITROGEN BLOOD LEVEL;

BLOOD Β-D-GLUCAN; IMMUNOCOMPROMISED HOST; PNEUMOCYSTIS JIROVECII PNEUMONIA; POLYMERASE CHAIN REACTION;

AGED; ANALYSIS OF VARIANCE; BETA-GLUCANS; DNA, FUNGAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 84903713998     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2013.09.004     Document Type: Article

References (33)

1. Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004;10: 1713-20 (Pubitemid 39319360)
2. Mansharamani N, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000;118:704-11
3. Limper A, Offord K, Smith T, W Martin. Pneumocystis carinii pneumonia. differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989;140:1204-9 (Pubitemid 19276197)
4. Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing Pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2009;135:655-61
5. Matsumura Y, Ito Y, Iinuma Y, Yasuma K, Yamamoto M, Matsushima A, et al. Quantitative real-time PCR and the (1/3)-b-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect 2012;18:591-7
6. Krajicek BJ, Thomas CF, Limper AH. Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment. Clin Chest Med 2009;30: 265-78
7. Caliendo AM, Hewitt PL, Allega JM, Keen A, Ruoff KL, Ferraro MJ. Performance of a PCR assay for detection of Pneumocystis carinii from respiratory specimens. J Clin Microbiol 1998;36:979-82 (Pubitemid 28146280)
8. Alvarez-Martínez MJ, Miró JM, Valls ME, Moreno A, Rivas PV, Solé M, et al. Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn Microbiol Infect Dis 2006;56:153-60 (Pubitemid 44488724)
9. Ribes JA, Limper AH, Espy MJ, Smith TF. PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity. J Clin Microbiol 1997;35:830-5 (Pubitemid 27146519)
10. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 2008;197:10-7 (Pubitemid 351263460)
11. Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, et al. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect 2011;17:1531-7
12. de Boer MG, Gelinck LB, van Zelst BD, van de Sande WW, Willems LN, van Dissel JT, et al. b-D-Glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients: a prospective study. J Infect 2011;62:93-100
13. Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, et al. Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest 2007;131:1173-80 (Pubitemid 46608722)
14. Sax PE, Komarow L, Finkelman MA, Grant PM, Andersen J, Scully E, et al. Blood (1/3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. Clin Infect Dis 2011;53:197-202
15. Held J, Koch M, Reischl U, Danner T, Serr A. Serum (1/3)-beta-D-glucan measurement as early indicator for Pneumocystis jirovecii pneumonia and evaluation of its prognostic value. Clin Microbiol Infect 2011;17:595-602
16. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. b-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011;52:750-70
17. Bollée G, Sarfati C, Thiéry G, Bergeron A, de Miranda S, Menotti J, et al. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest 2007;132:1305-10 (Pubitemid 47621008)
18. Kelley C, Checkley W, Mannino D, Franco-Paredes C, Del Rio C, Holguin F. Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii pneumonia in the United States (1986 to 2005). Chest 2009;136:190-7
19. Radhi S, Alexander T, Ukwu M, Saleh S, Morris A. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003. BMC Infect Dis 2008;8:118
20. Vincent J, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter P, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793-800 (Pubitemid 28527688)
21. De Pauw B, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21
22. Wakefield A, Pixley F, Banerji S, Sinclair K, Miller R, Moxon E, et al. Detection of Pneumocystis carinii with DNA amplification. Lancet 1990;336:451-3 (Pubitemid 20264212)
23. Vogel MN, Vatlach M, Weissgerber P, Goeppert B, Claussen CD, Hetzel J, et al. HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients. Eur J Radiol 2012;81:1315-20
24. Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, et al. 1,3-Beta- D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008;46:878-85 (Pubitemid 351417190)
25. Ellis M, Al-Ramadi B, Finkelman M, Hedstrom U, Kristensen J, Ali-Zadeh H, et al. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008;57:287-95 (Pubitemid 351358531)
26. Watanabe T, Yasuoka A, Tanuma J, Yazaki H, Honda H, Tsukada K, et al. Serum (1/3) beta-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin Infect Dis 2009;49:1128-31
27. Koga M, Koibuchi T, Kikuchi T, Nakamura H, Miura T, Iwamoto A, et al. Kinetics of serum b-D-glucan after Pneumocystis pneumonia treatment in patients with AIDS. Intern Med 2011;50:1397-401
28. Koo S, Baden LR, Marty FM. Post-diagnostic kinetics of the (1/3)-b-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia. Clin Microbiol Infect 2012;18:E122-7
29. Nakamura H, Tateyama M, Tasato D, Haranaga S, Yara S, Higa F, et al. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia. Intern Med 2009;48:195-202
30. Matsumura Y, Shindo Y, Iinuma Y, Yamamoto M, Shirano M, Matsushima A, et al. Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis 2011;11:76
31. Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis 2008;46:625-33 (Pubitemid 351263506)
32. Fernandez P, Torres A, Miro JM, Vieigas C, Mallolas J, Zamora L, et al. Prognostic factors influencing the outcome in Pneumocystis carinii pneumonia in patients with AIDS. Thorax 1995;50:668-71
33. Fei MW, Kim EJ, Sant CA, Jarlsberg LG, Davis JL, Swartzman A, et al. Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study. Thorax 2009;64:1070-6.